Comparative Treatment Patterns and Outcomes of Fulvestrant versus Everolimus Plus Exemestane for Postmenopausal Metastatic Breast Cancer Resistant to Aromatase Inhibitors in Real-World Experience

Overview of attention for article published in Therapeutics and Clinical Risk Management, June 2020

Altmetric Badge

About this Attention Score

Good Attention Score compared to outputs of the same age (66th percentile)
High Attention Score compared to outputs of the same age and source (83rd percentile)

So far, Altmetric has seen 1 blog post.

Source link : https://www.breast-cancers.com/2020/06/30/comparative-treatment-patterns-and-outcomes-of-fulvestrant-versus-ever-tc…